Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 4

1(50.0%)

N/A

1(50.0%)

2Total

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06566898Recruiting

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Role: lead

NCT07257952Not Yet Recruiting

APOs Associated With Respiratory Viral Infections Before and During Early Pregnancy

Role: lead

NCT06740552Completed

Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

Role: collaborator

NCT07281170Recruiting

Xinqiao High-risk Cohort of Diabetes(NICE)

Role: lead

NCT07088757Phase 4Recruiting

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Role: collaborator

NCT07161947Recruiting

Shanghai Clinical Cohort of Hyperglycemia in Pregnancy

Role: lead

NCT07125885Recruiting

Gongji Pregnancy Endorine Cohort Study

Role: lead

NCT07079813Not ApplicableNot Yet Recruiting

Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications

Role: collaborator

NCT06538441Active Not Recruiting

Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia

Role: lead

All 9 trials loaded